References
- Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60(11): 1524–34
- Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353(9168): 1959–64
- Rozen TD. Trigeminal neuralgia and glossopharyngeal neuralgia. Neurol Clin North Am 2004; 22(1): 185–206
- Smyth P, Greenough G, Stommel E. Familial trigeminal neuralgia: case reports and review of the literature. Headache 2003; 43(8): 910–5
- Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001; 124(Pt 12): 2347–60 [Erratum, Brain 2002; 125(Pt 3): 687]
- Burchiel KJ, Slavin KV. On the natural history of trigeminal neuralgia. Neurosurgery 2000; 46(1): 152–4
- Elias WJ, Burchiel KJ. Trigeminal neuralgia and other neuropathic pain syndromes of the head and face. Curr Pain Headache Rep 2002; 6(2): 115–24
- Kitt CA, Gruber K, Davis M, et al. Trigeminal neuralgia: opportunities for research and treatment. Pain 2000; 85(1–2): 3–7
- Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 2002; 95(3): 259–66
- Young RF, Vermeulen SS, Grimm P, et al. Gamma Knife radiosurgery for treatment of trigeminal neuralgia: idiopathic and tumor related. Neurology 1997; 48(3): 608–14
- Barker FG HI, Jannetta PJ, Bissonette DJ, et al. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 1996; 334(17): 1077–83
- Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004; 24(Suppl 1): 9–160
- Ward JB. Greater occipital nerve block. Semin Neurol 2003; 23(1): 59–62
- Lavin PJ, Workman R. Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids. Headache 2001; 41(9): 902–4
- Stojanovic MP. Stimulation methods for neuropathic pain control. Curr Pain Headache Rep 2001; 5(2): 130–7
- Kost RG, Straus SE. Postherpetic neuralgia—pathogenesis, treatment, and prevention. N Engl J Med 1996; 335(1): 32–42
- Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. BMJ 2003; 326(7392): 748–50
- Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 2000; 87(2): 121–9
- Gnann JW Jr, Whitley RJ. Herpes zoster. N Engl J Med 2002; 347(5): 340–6
- Pappagallo M, Haldey EJ. Pharmacological management of postherpetic neuralgia. CNS Drugs 2003; 17(11): 771–80
- Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002; 59(7): 1015–21
- Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000; 343(21): 1514–9